MedTrace Logo

Steroid Injection for Sickle Cell Arthropathy Pain Therapy

NCT05983055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-01-27

No results posted yet for this study

Summary

Sickle cell disease (SCD) is associated with arthropathy. Arthropathy may require periarticular corticosteroid injection therapy. This observational study examines efficacy, and safety of steroid injections in SCD patients. Data collection includes patient's gender, age, race, smoking history, alcohol intake, analgesic use, pain score, sleep quality, limb joint injections, post-injection analgesia, and post-injection complication. Pain is measured using numeric pain scale. Sleep quality is measured using Likert scale.

Conditions

Interventions

DRUG

Dexamethasone 20mg

Periarticular dexamethasone injection

Sponsors & Collaborators

  • Salem Anaesthesia Pain Clinic

    lead OTHER

Principal Investigators

  • Olumuyiwa Bamgbade, MD,FRCPC · Salem Anaesthesia Pain Clinic

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-30
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05983055 on ClinicalTrials.gov